Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rallybio Corporation - Common Stock (NQ:RLYB)

0.6327 +0.0074 (+1.18%)
Streaming Delayed Price Updated: 12:05 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 73,270
Open 0.6313
Bid (Size) 0.6325 (600)
Ask (Size) 0.6600 (1,000)
Prev. Close 0.6253
Today's Range 0.6256 - 0.6620
52wk Range 0.2201 - 1.240
Shares Outstanding 37,747,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline
Rallybio posts Q3 profit on one-time gain, extends cash runway to 2027, and advances its C5 inhibitor clinical pipeline. 
Via Chartmill
Topics Earnings
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Rallybio Corporation
Via Business Wire

Performance

YTD
-33.4%
-33.4%
1 Month
+23.8%
+23.8%
3 Month
+27.3%
+27.3%
6 Month
+110.3%
+110.3%
1 Year
-39.7%
-39.7%

More News

Read More
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
From Rallybio Corporation
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program
From Rallybio Corporation
Via Business Wire
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
Via FinancialNewsMedia
Topics Artificial Intelligence
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates
From Rallybio Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Top movers in Tuesday's session
Via Chartmill
Most active stocks in Tuesday's session
Via Chartmill
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
What's going on in today's session
Via Chartmill
Gapping stocks in Tuesday's session
Via Chartmill
Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
Via Benzinga
Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals
From Rallybio Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
From Rallybio Corporation
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates
From Rallybio Corporation
Via Business Wire
Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference
From Rallybio Corporation
Via Business Wire

Frequently Asked Questions

Is Rallybio Corporation - Common Stock publicly traded?
Yes, Rallybio Corporation - Common Stock is publicly traded.
What exchange does Rallybio Corporation - Common Stock trade on?
Rallybio Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rallybio Corporation - Common Stock?
The ticker symbol for Rallybio Corporation - Common Stock is RLYB on the Nasdaq Stock Market
What is the current price of Rallybio Corporation - Common Stock?
The current price of Rallybio Corporation - Common Stock is 0.6327
When was Rallybio Corporation - Common Stock last traded?
The last trade of Rallybio Corporation - Common Stock was at 11/10/25 12:05 PM ET
What is the market capitalization of Rallybio Corporation - Common Stock?
The market capitalization of Rallybio Corporation - Common Stock is 23.88M
How many shares of Rallybio Corporation - Common Stock are outstanding?
Rallybio Corporation - Common Stock has 24M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.